Ari Bousbib - IQVIA Holdings Insider

Q -- USA Stock  

USD 103.48  0.00  0.00%

  Director
Mr. Ari Bousbib is a Chairman of the Board, President, Chief Executive Officer of the Company. He assumed this position in October 2016 following the Merger of Quintiles and IMS Health. From 2010 until the Merger, Mr. Bousbib served as chairman and CEO of IMS Health. In 2014, he led the successful IPO of the company. Prior to joining IMS Health, Mr. Bousbib spent 14 years at United Technologies Corporationrationration, an aerospace, defense and building industries company. From 2008 until 2010, he served as President of UTCs Commercial Companies, including Otis Elevator Company, Carrier Corporationrationration, UTC Fire Security and UTC Power Inc. From 2002 until 2008, Mr. Bousbib was President of Otis, and from 2000 to 2002 he served as its Chief Operating Officer. Previously, Mr. Bousbib was a partner at Booz Allen Hamilton. Mr. Bousbib currently serves on the board of directors of The Home Depot, Inc. and is a member of the Harvard Medical School Health Care Policy Advisory Council. He previously served on the board of directors of Best Buy, Inc. and was appointed by the President of the United States to serve on the Presidents Commission on White House Fellowships
Age: 55  Director Since 2016  MBA    
919-998-2000  www.quintiles.com
Bousbib holds a MS Degree in Mathematics and Mechanical Engineering from the Ecole Superieure des Travaux Publics, Paris, and an M.B.A. from Columbia University.

Ari Bousbib Latest Insider Activity

Management Efficiency

The company has return on total asset of 4.03 % which means that for every 100 dollars spent on asset it generated profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 1.89 % implying that it made 1.89 on every $100 invested by shareholders.
The company has accumulated 9.77 B in total debt with debt to equity ratio (D/E) of 130.0 implying that the company may be unable to produce cash to meet its debt commitments. IQVIA Holdings has Current Ratio of 1.2 implying that it may have difficulties to pay its interest payments when they become due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Guowei WangSinovac Biotech Ltd
2018
Sanjay KhoslaZoetis
2013
Willie ReedZoetis
2014
David BullockOrigin Agritech Limited
2015
Pengfei LiSinovac Biotech Ltd
2018
Marc LippmanSeattle Genetics
2000
Bruce CarterDr Reddys Laboratories Limited
2008
Jue LeeSinovac Biotech Ltd
2012
Marc TessierLavigneRegeneron Pharmaceuticals
2011
Pinkston PeggySeattle Genetics
N/A
David GryskaSeattle Genetics
2005
Yuk LoSinovac Biotech Ltd
2006
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
Margaret McGlynnVertex Pharmaceuticals Incorpor
2011
Huda ZoghbiRegeneron Pharmaceuticals
2016
Omkar GoswamiDr Reddys Laboratories Limited
2000
Alfred GilmanRegeneron Pharmaceuticals
1990
Charles BakerRegeneron Pharmaceuticals
N/A
Fung HoiSinovac Biotech Ltd
2018
Terrence KearneyVertex Pharmaceuticals Incorpor
2011
Louise ParentZoetis
2013

Entity Summary

Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. IQVIA Holdings (Q) is traded on New York Stock Exchange in USA. It is located in 4820 Emperor Blvd., Durham, NC 27703, United States and employs 36,100 people.

IQVIA Holdings Leadership Team

Thomas Pike, CEO and Director
Ari Bousbib, Director
Michael Evanisko, Independent Director
Leonard Schaeffer, Independent Director
James Erlinger, Executive Vice President General Counsel, Secretary
John Danhakl, Director
Richard Staub, President - Research and Development Solutions
Michael McDonnell, CFO, Executive Vice President
Kevin Gordon, COO
John Leonard, Independent Director
James Fasano, Director
Jonathan Coslet, Director
John Connaughton, Director
Haiyuan Lo, Director
Ronald Rittenmeyer, Director
Dennis Gillings, Executive Chairman of the Board
Todd Sisitsky, Director
Jack Greenberg, Independent Director
Kevin Knightly, President - Information and Technology Solutions

Stock Performance Indicators

Did you try this?

Run Focused Opportunities Now

   

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Focused Opportunities
Currently Active Assets on Macroaxis
CRM   
Purchased a lot of shares of
few hours ago
Traded for 156.0
CRM   
Purchased a lot of shares of
few hours ago
Traded for 156.0
F   
Purchased over 300 shares of
few hours ago
Traded for 9.81
C   
Purchased over 40 shares of
few hours ago
Traded for 74.735
GM   
Purchased over 70 shares of
few hours ago
Traded for 36.08
Additionally take a look at Your Equity Center. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.
Search macroaxis.com